Investor Home


We are ProQR, a company on a mission to create new medicines for patients in need. We focus on a group of diseases called rare diseases, with a very high need for new medicines. Out of the approximately 7,000 rare diseases, less than 400 have a treatment, and we intend to change that. To treat these diseases we use RNA therapies, a technology that allows us to address inherited diseases that are caused by a genetic defect. Our focus is on diseases that are very severe or life threatening, and have limited treatment options. Amongst others we work on the development of new medicines for several forms of inherited blindness such as Leber’s congenital amaurosis and Usher syndrome, a lung disease called cystic fibrosis, and a debilitating skin disease named dystrophic epidermolysis bullosa. Read more

Share Performance

Copyright West LLC. Minimum 15 minutes delayed.

IR Contacts

ProQR Therapeutics N.V.
Phone: +31 88 166 7000
Lisa Hayes
Vice President of Investor Relations and Corporate Communications
Phone: +1 202 360 4855

Media Contact